- THIS ARTICLE
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Klapholz, S.
- Articles by Esposito, R. E.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Klapholz, S.
- Articles by Esposito, R. E.
A NEW MAPPING METHOD EMPLOYING A MEIOTIC REC- MUTANT OF YEAST
Sue Klapholz 1 and Rochelle Easton Esposito 2
1 Department of Biology, University of Chicago, Chicago, Illinois 60637
2 Department of Biology, and Committee on Genetics, University of Chicago, Chicago, Illinois 60637
A rapid new mapping method has been developed for localizing a dominant or recessive mutation to a particular chromosome of yeast. The procedure utilizes the ability of strains homozygous for the spo11-1 mutation to undergo chromosome segregation without appreciable recombination during sporulation. The level of sporulation in spo11-1/spo11-1 diploids is reduced and asci are often immature or abnormal in appearance; spore viability is less than 1%. The first step of the mapping procedure is the construction of a haploid spo11-1 strain carrying a recessive drug-resistance marker and the unmapped mutation(s). This strain is crossed to a set of three spo11-1 mapping tester strains containing, among them, a recessive marker on each chromosome. The resulting spo11-1/spo11-1 diploids are sporulated and plated on drug-containing medium. Viable meiotic products that express the drug-resistance marker due to chromosome haploidization are selectively recovered. These meiotic products are haploid for most, but generally not all, chromosomes. The level of disomy for individual chromosomes averages 19%. Each of the recessive chromosomal markers is expressed in approximately a third of the drug-resistant segregants. Ninety-eight percent of these segregants show no evidence of intergenic recombination. Thus, two markers located on the same chromosome, but on different homologs, are virtually never expressed in the same drug-resistant clone. The utility of this mapping procedure is demonstrated by confirming the chromosomal location of seven known markers, as well as by the assignment of a previously unmapped mutation, spo12-1, to chromosome VIII. In addition, the analysis of the products of spo11-1 meiosis indicates that several markers previously assigned to either chromosome XIV or chromosome XVII are actually on the same chromosome.
Submitted on November 11, 1981Accepted on December 5, 1981
This article has been cited by other articles:
![]() |
G. G. Tevzadze, J. V. Pierce, and R. E. Esposito Genetic Evidence for a SPO1-Dependent Signaling Pathway Controlling Meiotic Progression in Yeast Genetics, March 1, 2007; 175(3): 1213 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wagner, G. Price, and R. Rothstein The Absence of Top3 Reveals an Interaction Between the Sgs1 and Pif1 DNA Helicases in Saccharomyces cerevisiae Genetics, October 1, 2006; 174(2): 555 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bhuiyan and K. Schmekel Meiotic Chromosome Synapsis in Yeast Can Occur Without Spo11-Induced DNA Double-Strand Breaks Genetics, October 1, 2004; 168(2): 775 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Davidson, N. P. Young, G. G. Glick, and W. P. Wahls Meiotic chromosome segregation mutants identified by insertional mutagenesis of fission yeast Schizosaccharomyces pombe; tandem-repeat, single-site integrations Nucleic Acids Res., August 17, 2004; 32(14): 4400 - 4410. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Shor, S. Gangloff, M. Wagner, J. Weinstein, G. Price, and R. Rothstein Mutations in Homologous Recombination Genes Rescue top3 Slow Growth in Saccharomyces cerevisiae Genetics, October 1, 2002; 162(2): 647 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Rutkowski and R. E. Esposito Recombination Can Partially Substitute for SPO13 in Regulating Meiosis I in Budding Yeast Genetics, August 1, 2000; 155(4): 1607 - 1621. [Abstract] [Full Text] |
||||
![]() |
T. Suzuki, H. Park, N. M. Hollingsworth, R. Sternglanz, and W. J. Lennarz PNG1, a Yeast Gene Encoding a Highly Conserved Peptide:N-glycanase J. Cell Biol., May 29, 2000; 149(5): 1039 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. E. Oluwatosin and P. M. Kane Mutations in the Yeast KEX2 Gene Cause a Vma--Like Phenotype: a Possible Role for the Kex2 Endoprotease in Vacuolar Acidification Mol. Cell. Biol., March 1, 1998; 18(3): 1534 - 1543. [Abstract] [Full Text] |
||||
![]() |
Y. E. Oluwatosin and P. M. Kane Mutations in the CYS4 Gene Provide Evidence for Regulation of the Yeast Vacuolar H+-ATPase by Oxidation and Reduction in Vivo J. Biol. Chem., October 31, 1997; 272(44): 28149 - 28157. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Joachimiak, G. Tevzadze, J. Podkowinski, R. Haselkorn, and P. Gornicki Wheat cytosolic acetyl-CoA carboxylase complements an ACC1 null mutation in yeast PNAS, September 2, 1997; 94(18): 9990 - 9995. [Abstract] [Full Text] [PDF] |
||||





